Hello and welcome to my Nuzzel newsletter!
I'm Ronny, International Neuroendocrine Cancer Advocate. Independent Patient Voice. Award winning WEGO Health Patient Leader, Cure Today Contributor, Featured 1 million + Blogger, Veteran.
The build up to my diagnosis was covered in this blog (Diagnosis – I'm no longer in Control). This chance scenario, led to a set of routine blood rests which highlighted a low haemoglobin score. It was low enough to be referred to a…
The New York Times
– Feb 24, 5:18 AM
|Johnson & Johnson's vaccine strongly protects against severe illness and may reduce spread of the virus. Continue reading the main story Covid-19: U.S. Vaccine Production and Supply Increase After Snowstorms Caused Delays The one-shot coronavirus…
The New York Times
– Feb 22, 11:30 PM
A few years ago, routine lab tests showed that Susan Glickman Weinberg, then a 65-year-old clinical social worker in Los Angeles, had a hemoglobin A1C reading of 5.8 percent, barely above normal. “This is considered prediabetes,” her…
Nearly half of people who had potential cancer symptoms in the first wave of the COVID-19 pandemic did not contact their GP, a Cancer Research UK and Cardiff University study suggests. Initial findings of the UK-wide survey, focusing on the…
As someone who was born and raised in the Scotland, and lived most of my life in the UK, I'm no stranger to inclement weather. In my 29 years years in the military, the weather was no excuse to do nothing, whether it was training or the real thing.
It's estimated that around 5-10% of Neuroendocrine Neoplasms (NENs) have an unknown primary – what that means is cancer cells have been found in the body but the place the cancer began remains unknown. I wrote about this issue in more depth…
Ronny Allan - Living with Neuroendocrine Cancer
– Jul 7, 2015, 7:00 AM
Although initially considered rare tumours up until 10 years ago, the most recent data indicates the incidence of NETs has increased exponentially over the last 4 decades and they are as common as Myeloma, Testicular Cancer, and Hodgkin's Lymphoma.